Cargando…
METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is still one of the major causes of cancer-related mortality across the globe. Therefore, there is a dire need to identify early specific and sensitive biomarkers or drug targets of LUAD for developing improved diagnosis and clinical management. We aimed to inv...
Autores principales: | Ali, Jawad, Liu, Wenwen, Duan, Wenzhe, Liu, Chang, Song, Jing, Ali, Sameen, Li, Encheng, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576055/ https://www.ncbi.nlm.nih.gov/pubmed/33240979 http://dx.doi.org/10.21037/atm-20-4574 |
Ejemplares similares
-
Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril
por: Maldonato, Benjamin J., et al.
Publicado: (2021) -
METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
por: Li, Rong, et al.
Publicado: (2022) -
Methyltransferase-like protein 7A (METTL7A) promotes cell survival and osteogenic differentiation under metabolic stress
por: Lee, Eugene, et al.
Publicado: (2021) -
Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma
por: Song, Huibin, et al.
Publicado: (2022) -
The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer
por: Yang, Zhiqian, et al.
Publicado: (2023)